Beat AML® Study Provides New Data on 14-Day vs. 28-Day Venetoclax-Azacitidine Treatment in AML

Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

Friends of PAHO Leads Call from Health, Security, and Business Leaders for Continued U.S. Leadership in the Pan American Health Organization

BRIJ Medical Awarded Breakthrough Technology Designation for BRIJ-SEAL™ Advanced Wound Sealant with Premier, Inc.

Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection